Skip to main content
SpringerLink
Log in

Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients

  • Review Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adelman RD (1978) Neonatal hypertension.Pediatr Clin North Am 25:99

    Google Scholar 

  2. Artman M, Graham TP (1987) Guidelines for vasodilator therapy of congestive heart failure in infants and children.Am Heart J 113:994–1005

    Google Scholar 

  3. Bifano H, et al. (1982) Treatment of neonatal hypertension with captopril.J Pediatr 100:145

    Google Scholar 

  4. Bing J, Poulsen K (1970) Effect of anti-angiotensin II on blood pressure and sensitivity to angiotensin and renin.Acta Pathol Microbiol Scand [A]78:6

    Google Scholar 

  5. Biolaz J, Burnier M, Turini GA, et al. (1981) Three new longacting converting-enzyme activity and response to angiotensin I.Clin Pharmacol Ther 29:665

    Google Scholar 

  6. Boucek MM, et al. (1984) Elevated plasma renin in lambs with ventricular septal defect and hemodynamic improvement following captopril [abstract]. American Heart Association Meeting

  7. Brunner DB, Desponds G, Biollaz J, et al. (1981) Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysin analogue on the components of the renin system in healthy subjects.Br J Clin Pharmacol 11:461

    Google Scholar 

  8. Brunner HR, Gavras H, Laragh JHM, et al. (1973) Angiotensin II blockade in man by Sar1-ala8-angiotensin II for understanding and treatment of high blood pressure.Lancet 2:1045

    Google Scholar 

  9. Brunner HR, Kirshman JD, Sealy JE, et al. (1971) Hypertension of renal origin: Evidence for two different mechanisms.Science 174:1344

    Google Scholar 

  10. Brunner HR, Nussberger J, Waeber B (1985) The present molecules of converting enzyme inhibitors.J Cardiovasc Pharmacol 7:2S

    Google Scholar 

  11. Case DB, et al. (1979) Successful acute and chronic treatment of severe and malignant hypertension with oral converting enzyme inhibitor captopril [Abstract].Circulation 59 [suppl 2],60:II-130

    Google Scholar 

  12. Case DB, et al. (1982) Long-term efficacy of captopril in renovascular and essential hypertension.Am J Cardiol 49:1440

    Google Scholar 

  13. Casta A, et al. (1982) Effective use of captopril in postoperative paradoxical hypertension of coarctation of the aorta.Clin Cardiol 5:551

    Google Scholar 

  14. Cody RJ, et al. (1978) Hemodynamics of orally active converting enzyme inhibitors (SQ 20881) in hypertensive patients.Clin Sci Mol Med 55:453

    Google Scholar 

  15. Collier JG, Robinson BF, Vane JR (1973) Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P.9a or SQ 20881) which inhibits converting enzyme.Lancet 1:72

    Google Scholar 

  16. Duchin KL, et al. (1982) Captopril kinetics.Clin Pharmacol Ther 31:452

    Google Scholar 

  17. Eide I, Aars H (1970) Renal hypertension in rabbits immunized with angiotensin II.Scand J Clin Lab Invest 25:119

    Google Scholar 

  18. Fagard R, et al. (1982) Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patients.Circulation 65:33

    Google Scholar 

  19. Ferreira SH (1965) A bradykinin-potentiating factor (BPE) present in the venom of Bothrops jararaca.Br J Pharmacol Chemother 24:163

    Google Scholar 

  20. Fouad FM, et al. (1980) Contrasts and similarities of acute hemodynamic responses to specific antagonism of angiotensin II (Sar, Thr, A II) and to inhibition of converting enzyme (captopril).Circulation 61:163

    Google Scholar 

  21. Friedman A, et al (1980) Effective use of captopril (angiotensin converting-enzyme inhibitor) in severe childhood hypertension.J Pediatr 97:664

    Google Scholar 

  22. Gavras H, et al. (1978) Antihypertensive effect of oral angiotensin converting-enzyme inhibitor SQ 14225 in man.N Engl J Med 298:991

    Google Scholar 

  23. Grossman E, et al. (1984) Clinical use of captopril in Takayasu's disease.Arch Intern Med 144:95

    Google Scholar 

  24. Hamilton DV, Maidment G (1981) Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation.JR Soc Med 74:357

    Google Scholar 

  25. Hedwall PR (1968) Effect of rabbit antibodies against angiotensin II on the pressor response to angiotensin II and renal hypertension in the rat.Br J Pharmacol Chemother 34:623

    Google Scholar 

  26. Horowitz JD, et al. (1981) Effects of captopril (SQ 14225) in a patient with primary pulmonary hypertension.Postgrad Med J 57:115

    Google Scholar 

  27. Ita CE, et al. (1989) Distribution of captopril to fetuses and milk of rats.Xenobiotica (in press)

  28. Kimoto S (1979) The history and present status of aortic surgery in Japan, particularly for aortitis syndrome.J Cardiovasc Surg 20:107

    Google Scholar 

  29. Kripalani KJ, et al. (1980) Disposition of captoril in normal subjects.Clin Pharmacol Ther 27:636

    Google Scholar 

  30. Leibau G, et al. (1982) Captopril in congestive heart failure.Br J Clin Pharmacol 14:193S

    Google Scholar 

  31. Leier CV, et al. (1983) Captopril in primary pulmonary hypertension.Circulation 67:155

    Google Scholar 

  32. Lloyd TR, Mahoney LT, Knoedel D, Marvin WJ Jr, Lauer RM (1987) Pharmacokinetics of oral enalapril in infants with congestive heart failure [Abstract].Circulation 76(suppl IV):IV-266

    Google Scholar 

  33. Macda T, et al. (1979) Studies on the metabolism of a new antihypertensive agent, SQ 14225 (captopril). I. In vitro studies on the binding to plasma protein and behavior in blood. In: Proceedings of the 99th Annual Meeting of the Pharmaceutical Society of Japan, Sapporo, August 28–30

  34. Marmor A, Schneeweiss A. (1989) A single dose of cilazapril improves diastolic cardiac function in hypertensive patients.Am J Med (in press)

  35. Miller K, Atkin B, Puppala B, Fisher M (1989) Management of renal vascular hypertension in the high risk neonate with intravenous (iv) enalaprilat (MK422). An abstract presented at the International Symposium on ACE Inhibition, London, February 14–17

  36. Mookerjee S, et al. (1983) Acute effects of captopril on cardiopulmonary function, hemodynamics and renin-angiotensinaldosterone-bradykinin profile in hypertension.Am Heart J 106:106

    Google Scholar 

  37. Narmor AM, Traub Z, Churi A, Troshar D, Schneeweiss A (1988) Comparative effects of captopril and nifedipine on diastolic and systolic cardiac function in elderly hypertensive patients.J Hypertens 6(suppl 1):S101-S103

    Google Scholar 

  38. Oberfield SE, et al. (1979) use of the orgal angiotension I-converting enzyme inhibitor (captopril) in childhood malignant hypertension.J Pediatr 95:641

    Google Scholar 

  39. Oberfield SE, Rapaport R, Levine LS, New MI (1982) Captopril.Pediatr Ann 11:614

    Google Scholar 

  40. O'dea RF, Mirkin BL, Aluard CT, Sinaiko AR (1988) Treatment of neonatal hypertension with captopril.J Pediatr 113:403–406

    Google Scholar 

  41. Ondetti MA, Rubin B, Cushman DW (1977) Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents.Science 196:441

    Google Scholar 

  42. Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Cleaver ER, Kocy O (1971) Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca: Isolation, elucidation of structure and synthesis.Biochemistry 10:4033

    Google Scholar 

  43. Patchett, AA, Haris GW, Tristram EW, et al. (1980) A new class of angiotensin-converting enzyme inhibitors.Nature 288:280

    Google Scholar 

  44. Plumer LB, Kaplan GW, Mendoza SA (1976) Hypertension in infants: A complication of umbilical arterial catheterization.J Pediatr 89:802

    Google Scholar 

  45. Reyes AJ, Leary WP, Acosta-Barrios TN (1985) Once daily administration of captopril and hypotensive effect.J Cardiovasc Pharmacol 7:16S

    Google Scholar 

  46. Rich S, et al. (1982) Captopril as treatment for patients with pulmonary hypertension.Br Heart J 48:272

    Google Scholar 

  47. Seguchi M, Nakazawa M, Hirayama K, Takao A (1988) Enalapril therapy in congested infants and children with heart diseases [Abstract].Circulation 78:II-201

    Google Scholar 

  48. Sinaiko AR, et al. (1983) Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease.J Pediatr 103:799

    Google Scholar 

  49. Singhvi SM, et al. (1982) Effect of food on the bioavailability of captopril in healthy subjects.J Clin Pharmacol 22:135

    Google Scholar 

  50. Veterans Administration Co-operative Study Group on Anti-hypertensive Agents (1982) Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.Br J Clin Pharmacol 14:97S

    Google Scholar 

  51. Veterans Administration Co-operative Study Group on Antihypertensive Agents (1982) Captopril in hypertension.63[suppl 8]:443S

  52. Wakerin GE (1958) Antibodies to renin as proof of the pathogenesis of sustained renal hypertension.Circulation 17:653

    Google Scholar 

  53. Weiser RA, Johnson AG, Hoobler SW (1969) The effect of antirenin on the blood pressure of the rat with experimental renal hypertension.Lab Invest 20:326

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tel-Aviv, Israel

    Adam Schneeweiss

Authors
  1. Adam Schneeweiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneeweiss, A. Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients. Pediatr Cardiol 11, 199–207 (1990). https://doi.org/10.1007/BF02238367

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02238367

Keywords

Search

Navigation